| LitCovid-TimeML | | | 426 K | | Jin-Dong Kim | 2023-11-29 | Developing | |
| LitCovid-PD-GO-BP | | Terms for biological prosesses, as defined in GO | 374 K | | Jin-Dong Kim | 2023-11-29 | Developing | |
| dailymed_spl | | Annotation of indications from DailyMed structured product labels | 0 | | micheldumontier | 2023-11-29 | Developing | |
| bionlp-ost-19-BB-norm-ner-train | | | 2.45 K | | ldeleger | 2023-11-29 | Developing | |
| PubMed-2000 | | abstracts published in 2000. | 0 | | Jin-Dong Kim | 2023-11-29 | Developing | |
| glycobiology-test | | | 27 | | Jin-Dong Kim | 2023-11-29 | Developing | |
| KoreanFN-example | | Korean FrameNet example | 6 | | Jin-Dong Kim | 2023-11-29 | Developing | |
| Training_Data_English_fr_en | | | 0 | | wmtbio | 2023-11-29 | Developing | |
| Training_Data_Chinese_zh_en | | | 0 | | wmtbio | 2023-11-29 | Developing | |
| PMA_age_indications | | | 1.57 K | | therightstef | 2023-11-29 | Developing | |
| Training_Data_English_zh_en | | | 0 | | wmtbio | 2023-11-29 | Developing | |
| NER-microbes | | | 10 | | Shuichi Kawashima | 2023-11-29 | Developing | |
| LitCovid-sample-Enju | | | 13.1 K | | Jin-Dong Kim | 2023-11-29 | Developing | |
| OryzaGP_2021_v2 | | OryzaGP_2021_v2 will use a second annotator | 208 K | | larmande | 2023-11-29 | Developing | |
| OryzaGP_2020_TO-all | | | 0 | Pierre Larmande | larmande | 2023-11-29 | Developing | |
| OryzaGP_2020 | | OryzaGP is a dataset of pubmed abstract related to Oryza sativa species | 0 | Pierre Larmande | larmande | 2023-11-29 | Developing | |
| hydroxychloroquine | | | 2.59 K | | Jin-Dong Kim | 2023-11-29 | Developing | |
| ICD10 | | Annotation for disease names as defined in ICD10 | 1.6 K | DBCLS | Jin-Dong Kim | 2023-11-29 | Developing | |
| KAIST_NLP_Annotation7 | | | 4.64 K | | kaist_nlp | 2023-11-29 | Developing | |
| KAIST_NLP_Annotation3 | | | 4.73 K | | kaist_nlp | 2023-11-29 | Developing | |
